tiprankstipranks
Trending News
More News >
Yunkang Group Limited (HK:2325)
:2325
Hong Kong Market
Advertisement

Yunkang Group Limited (2325) Price & Analysis

Compare
0 Followers

2325 Stock Chart & Stats


Financials

2325 FAQ

What was Yunkang Group Limited’s price range in the past 12 months?
Yunkang Group Limited lowest stock price was HK$2.10 and its highest was HK$10.60 in the past 12 months.
    What is Yunkang Group Limited’s market cap?
    Yunkang Group Limited’s market cap is HK$2.73B.
      When is Yunkang Group Limited’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Yunkang Group Limited’s earnings last quarter?
      Currently, no data Available
      Is Yunkang Group Limited overvalued?
      According to Wall Street analysts Yunkang Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Yunkang Group Limited pay dividends?
        Yunkang Group Limited pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 0.46%. See more information on Yunkang Group Limited dividends here
          What is Yunkang Group Limited’s EPS estimate?
          Yunkang Group Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Yunkang Group Limited have?
          Yunkang Group Limited has 621,250,500 shares outstanding.
            What happened to Yunkang Group Limited’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Yunkang Group Limited?
            Currently, no hedge funds are holding shares in HK:2325

            Yunkang Group Limited Stock Smart Score

            Company Description

            Yunkang Group Limited

            Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. In addition, the company offers diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; healthcare technology development; and project investment. It provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.
            Similar Stocks
            Company
            Price & Change
            Follow
            MicroPort CardioFlow Medtech Corp.
            Beijing Airdoc Technology Co. Ltd. Class H
            C-MER Eye Care Holdings Limited
            Mega Genomics Limited
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis